Actualités VG Life Sciences Inc (PK) - VGLS | Actions OTCMarkets

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

Premium

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

UNITED STATES SECURITIES AND EXCHANGE...

Notification That Annual Report Will Be Submitted Late (nt 10-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

VG Life Sciences Granted Combination Cancer Drug Patent

VG Life Sciences Granted Combination Cancer Drug Patent U.S. Patent Covers Group of Compounds Combined With Existing Treatments To Fight...

VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015

VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015 PR Newswire SANTA BARBARA, Calif., June 16, 2015 SANTA...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT...

Quarterly Report (10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT...

Current Report Filing (8-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUA...

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

Annual Report (10-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) [X] ...

Notification That Annual Report Will Be Submitted Late (nt 10-k)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 12b-25 NOTIFICATION OF LATE...

Forums

Afficher les forums

Aucune Discussion Trouvée

Ajouter une Discussion

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

VG Life Sciences Inc (PK) (VGLS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

VGLS Actualités

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Quarterly Report (10-q)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

VG Life Sciences Granted Combination Cancer Drug Patent

VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Annual Report (10-k)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Donnée du Marché

Actualité

Outils

Donnée du Marché

Discover

Hot Features

Follow Feed

Flux des Options

Moniteur

VG Life Sciences Inc (PK) (VGLS) Actualités

VG Life Sciences Inc (PK) (VGLS)

Discussions et idées de trading en temps réel : négociez en toute confiance avec notre puissante plateforme.

VGLS Actualités

Termination of Registration of a Class of Security Under Section 12(g) (15-12g)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Current Report Filing (8-k)

Quarterly Report (10-q)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Quarterly Report (10-q)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

VG Life Sciences Granted Combination Cancer Drug Patent

VGLS Notes Key Patents, License and Other Major Achievements in the First Half of 2015

Current Report Filing (8-k)

Quarterly Report (10-q)

Current Report Filing (8-k)

Notification That Quarterly Report Will Be Submitted Late (nt 10-q)

Annual Report (10-k)

Notification That Annual Report Will Be Submitted Late (nt 10-k)

Forums

Dernières Valeurs Consultées

Société

Entreprise

Popular

Obtenir l'application

Supprimer les publicités